Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,879 | 125,987 | 102,891 | 63,547 | 417,195 |
| Marketable Securities | 83,246 | 0 | 14,857 | 128,134 | 0 |
| Receivables | 18,418 | 122,334 | 260,522 | 109,964 | 123,022 |
| Inventories | 3,172 | 4,207 | 62,605 | 38,791 | 37,642 |
| Other current assets | 6,233 | 82,402 | 11,099 | 22,918 | 10,798 |
| TOTAL | $206,706 | $341,583 | $475,631 | $381,234 | $602,323 |
| Non-Current Assets | |||||
| PPE Net | 1,345 | 2,576 | 5,119 | 8,754 | 7,813 |
| Intangibles | 46,239 | 53,646 | 71,673 | 5,931 | 0 |
| Other Non-Current Assets | 4,053 | 50,728 | 77,181 | 84,928 | 69,198 |
| TOTAL | $51,637 | $106,950 | $153,973 | $99,613 | $77,011 |
| Total Assets | $258,343 | $448,533 | $629,604 | $480,847 | $679,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,915 | 28,456 | 35,219 | 11,526 | 16,159 |
| Accrued Expenses | 130,471 | 254,525 | 296,552 | 127,168 | 149,168 |
| TOTAL | $140,386 | $282,981 | $331,771 | $138,694 | $165,327 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,051 | 36,698 | 246,481 | 245,483 | 75,513 |
| Other Non-Current Liabilities | 19,892 | 260,844 | 244,777 | 234,088 | 340,768 |
| TOTAL | $56,943 | $297,542 | $491,258 | $479,571 | $416,281 |
| Total Liabilities | $197,329 | $580,523 | $823,029 | $618,265 | $581,608 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,890 | 115,897 | 112,715 | 79,610 | 77,275 |
| Common Shares | 12 | 12 | 11 | 8 | 7 |
| Retained earnings | -1,382,969 | -1,550,993 | -1,579,500 | -1,341,608 | -1,049,854 |
| Other shareholders' equity | -195 | -275 | -248 | -249 | -270 |
| TOTAL | $61,014 | $-131,990 | $-193,425 | $-137,418 | $97,726 |
| Total Liabilities And Equity | $258,343 | $448,533 | $629,604 | $480,847 | $679,334 |